These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 32151684)

  • 1. Complement-dependent synapse loss and microgliosis in a mouse model of multiple sclerosis.
    Hammond JW; Bellizzi MJ; Ware C; Qiu WQ; Saminathan P; Li H; Luo S; Ma SA; Li Y; Gelbard HA
    Brain Behav Immun; 2020 Jul; 87():739-750. PubMed ID: 32151684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted Complement Inhibition at Synapses Prevents Microglial Synaptic Engulfment and Synapse Loss in Demyelinating Disease.
    Werneburg S; Jung J; Kunjamma RB; Ha SK; Luciano NJ; Willis CM; Gao G; Biscola NP; Havton LA; Crocker SJ; Popko B; Reich DS; Schafer DP
    Immunity; 2020 Jan; 52(1):167-182.e7. PubMed ID: 31883839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement C3 mediates early hippocampal neurodegeneration and memory impairment in experimental multiple sclerosis.
    Bourel J; Planche V; Dubourdieu N; Oliveira A; Séré A; Ducourneau EG; Tible M; Maitre M; Lesté-Lasserre T; Nadjar A; Desmedt A; Ciofi P; Oliet SH; Panatier A; Tourdias T
    Neurobiol Dis; 2021 Dec; 160():105533. PubMed ID: 34673149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet-Activating Factor Receptors Mediate Excitatory Postsynaptic Hippocampal Injury in Experimental Autoimmune Encephalomyelitis.
    Bellizzi MJ; Geathers JS; Allan KC; Gelbard HA
    J Neurosci; 2016 Jan; 36(4):1336-46. PubMed ID: 26818520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced Microglial Activity and Enhanced Glutamate Transmission in the Basolateral Amygdala in Early CNS Autoimmunity.
    Acharjee S; Verbeek M; Gomez CD; Bisht K; Lee B; Benoit L; Sharkey KA; Benediktsson A; Tremblay ME; Pittman QJ
    J Neurosci; 2018 Oct; 38(42):9019-9033. PubMed ID: 30185466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV Tat causes synapse loss in a mouse model of HIV-associated neurocognitive disorder that is independent of the classical complement cascade component C1q.
    Hammond JW; Qiu WQ; Marker DF; Chamberlain JM; Greaves-Tunnell W; Bellizzi MJ; Lu SM; Gelbard HA
    Glia; 2018 Dec; 66(12):2563-2574. PubMed ID: 30325063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement tunes glutamate release and supports synaptic impairments in an animal model of multiple sclerosis.
    Olivero G; Taddeucci A; Vallarino G; Trebesova H; Roggeri A; Gagliani MC; Cortese K; Grilli M; Pittaluga A
    Br J Pharmacol; 2024 Jun; 181(12):1812-1828. PubMed ID: 38369641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement C3-Deficient Mice Fail to Display Age-Related Hippocampal Decline.
    Shi Q; Colodner KJ; Matousek SB; Merry K; Hong S; Kenison JE; Frost JL; Le KX; Li S; Dodart JC; Caldarone BJ; Stevens B; Lemere CA
    J Neurosci; 2015 Sep; 35(38):13029-42. PubMed ID: 26400934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Connexin 30 Deficiency Attenuates Chronic but Not Acute Phases of Experimental Autoimmune Encephalomyelitis Through Induction of Neuroprotective Microglia.
    Fang M; Yamasaki R; Li G; Masaki K; Yamaguchi H; Fujita A; Isobe N; Kira JI
    Front Immunol; 2018; 9():2588. PubMed ID: 30464764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
    Gentile A; Musella A; Bullitta S; Fresegna D; De Vito F; Fantozzi R; Piras E; Gargano F; Borsellino G; Battistini L; Schubart A; Mandolesi G; Centonze D
    J Neuroinflammation; 2016 Aug; 13(1):207. PubMed ID: 27566665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Mixed-Lineage Kinase Inhibitor URMC-099 Protects Hippocampal Synapses in Experimental Autoimmune Encephalomyelitis.
    Bellizzi MJ; Hammond JW; Li H; Gantz Marker MA; Marker DF; Freeman RS; Gelbard HA
    eNeuro; 2018; 5(6):. PubMed ID: 30627663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3-dependent mechanism of microglial priming relevant to multiple sclerosis.
    Ramaglia V; Hughes TR; Donev RM; Ruseva MM; Wu X; Huitinga I; Baas F; Neal JW; Morgan BP
    Proc Natl Acad Sci U S A; 2012 Jan; 109(3):965-70. PubMed ID: 22219359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial Pruning: Relevance for Synaptic Dysfunction in Multiple Sclerosis and Related Experimental Models.
    Geloso MC; D'Ambrosi N
    Cells; 2021 Mar; 10(3):. PubMed ID: 33804596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Changes in Exo- and Endocytosis in the EAE Mouse Model of Multiple Sclerosis Correlate with Decreased Synaptic Ribbon Size and Reduced Ribbon-Associated Vesicle Pools in Rod Photoreceptor Synapses.
    Kesharwani A; Schwarz K; Dembla E; Dembla M; Schmitz F
    Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement C1q/C3-CR3 signaling pathway mediates abnormal microglial phagocytosis of synapses in a mouse model of depression.
    Han QQ; Shen SY; Liang LF; Chen XR; Yu J
    Brain Behav Immun; 2024 Jul; 119():454-464. PubMed ID: 38642614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glial pathology and retinal neurotoxicity in the anterior visual pathway in experimental autoimmune encephalomyelitis.
    Jin J; Smith MD; Kersbergen CJ; Kam TI; Viswanathan M; Martin K; Dawson TM; Dawson VL; Zack DJ; Whartenby K; Calabresi PA
    Acta Neuropathol Commun; 2019 Jul; 7(1):125. PubMed ID: 31366377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype.
    Hou B; Zhang Y; Liang P; He Y; Peng B; Liu W; Han S; Yin J; He X
    Cell Death Dis; 2020 May; 11(5):377. PubMed ID: 32415059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-142-3p Is a Key Regulator of IL-1β-Dependent Synaptopathy in Neuroinflammation.
    Mandolesi G; De Vito F; Musella A; Gentile A; Bullitta S; Fresegna D; Sepman H; Di Sanza C; Haji N; Mori F; Buttari F; Perlas E; Ciotti MT; Hornstein E; Bozzoni I; Presutti C; Centonze D
    J Neurosci; 2017 Jan; 37(3):546-561. PubMed ID: 28100738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement C1q-C3-associated synaptic changes in multiple sclerosis hippocampus.
    Michailidou I; Willems JG; Kooi EJ; van Eden C; Gold SM; Geurts JJ; Baas F; Huitinga I; Ramaglia V
    Ann Neurol; 2015 Jun; 77(6):1007-26. PubMed ID: 25727254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.
    Ziehn MO; Avedisian AA; Tiwari-Woodruff S; Voskuhl RR
    Lab Invest; 2010 May; 90(5):774-86. PubMed ID: 20157291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.